Literature DB >> 19084049

Demyelination of the hippocampus is prominent in the cuprizone model.

Paraskevi N Koutsoudaki1, Thomas Skripuletz, Viktoria Gudi, Darius Moharregh-Khiabani, Herbert Hildebrandt, Corinna Trebst, Martin Stangel.   

Abstract

In multiple sclerosis demyelination not only affects the white matter, but also the grey matter of the brain. We have previously reported that in the murine cuprizone model for demyelination lesions occur in addition to the corpus callosum also in the neocortex and hippocampus. In the current study, we provide a detailed characterization of hippocampal demyelination in the cuprizone model. Male C57BL/6 mice were challenged with 0.2% cuprizone for 6 weeks. Defined structures within the hippocampus were investigated at week 0 (control), 3, 4, 4.5, 5, 5.5, and 6. Demyelination affected all hippocampal structures analyzed and was complete after 6 weeks of cuprizone treatment. Between the distinct hippocampal structures the temporal pattern of demyelination varied considerably. Furthermore, infiltration of activated microglia as well as astrogliosis was detected. In summary, cuprizone feeding provides a useful model for studying demyelination processes in the mouse hippocampus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084049     DOI: 10.1016/j.neulet.2008.11.058

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

1.  Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Authors:  Andrew J Steelman; Jeffrey P Thompson; Jianrong Li
Journal:  Neurosci Res       Date:  2011-10-12       Impact factor: 3.304

2.  Beneficial effects of minocycline on cuprizone induced cortical demyelination.

Authors:  Thomas Skripuletz; Elvira Miller; Darius Moharregh-Khiabani; Alexander Blank; Refik Pul; Viktoria Gudi; Corinna Trebst; Martin Stangel
Journal:  Neurochem Res       Date:  2010-06-11       Impact factor: 3.996

Review 3.  The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.

Authors:  Robert P Murphy; Keith J Murphy; Mark Pickering
Journal:  Bioengineered       Date:  2012-11-12       Impact factor: 3.269

4.  Diverse Gene Expressions in the Prediction of Cuprizone-Induced Demyelination.

Authors:  Seung Ro Han; Yun Hee Kang; Seung-Min Yoo; Myung-Shin Lee; Seung-Hoon Lee
Journal:  Neurotox Res       Date:  2020-01-08       Impact factor: 3.911

Review 5.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

6.  Analysis of structural and molecular events associated with adult rat optic chiasm and nerves demyelination and remyelination: possible role for 3rd ventricle proliferating cells.

Authors:  Sabah Mozafari; Mohammad Javan; Mohammad Amin Sherafat; Javad Mirnajafi-Zadeh; Motahareh Heibatollahi; Shahram Pour-Beiranvand; Taki Tiraihi; Abolhasan Ahmadiani
Journal:  Neuromolecular Med       Date:  2011-02-03       Impact factor: 3.843

7.  FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.

Authors:  Amanda J Mierzwa; Yong-Xing Zhou; Norah Hibbits; Adam C Vana; Regina C Armstrong
Journal:  Neurosci Lett       Date:  2013-05-14       Impact factor: 3.046

8.  Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.

Authors:  Tomoaki Tezuka; Makoto Tamura; Mari A Kondo; Masaki Sakaue; Kinya Okada; Kana Takemoto; Atsushi Fukunari; Keiko Miwa; Hiromitsu Ohzeki; Shin-ichi Kano; Hiroshi Yasumatsu; Akira Sawa; Yasushi Kajii
Journal:  Neurobiol Dis       Date:  2013-07-16       Impact factor: 5.996

9.  Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.

Authors:  Diara A Santiago González; Veronica T Cheli; Norma N Zamora; Tenzing N Lama; Vilma Spreuer; Geoffrey G Murphy; Pablo M Paez
Journal:  J Neurosci       Date:  2017-09-12       Impact factor: 6.167

Review 10.  Modeling multiple sclerosis in laboratory animals.

Authors:  Bettina Schreiner; Frank L Heppner; Burkhard Becher
Journal:  Semin Immunopathol       Date:  2009-10-03       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.